Adcetris 50 mg for Intravenous Drip Infusion - PowerPoint PPT Presentation
Title:
Adcetris 50 mg for Intravenous Drip Infusion
Description:
Adcetris 50 mg for intravenous drip infusion is specifically an ADC which is known to deliver an antineoplastic agent that results in the apoptotic cell death selectively in the CD30 expressing tumor cells. The adcetris 50 mg is an anti-cancer medication and it is used to treat patients with Hodgkin's lymphoma, and systemic anaplastic large cell lymphoma. This medication works by slowing or inhibiting the growth of cancer cells. – PowerPoint PPT presentation
Number of Views:14
Title: Adcetris 50 mg for Intravenous Drip Infusion
1
ADCETRIS (brentuximab Vedotin)
- Hodgkin lymphoma Treatment
2
Commom Adcertris Side Effects
- Low blood counts .
- Peripheral neuropathy (numbness and tingling of
the hands and feet) - Fatigue (feeling tired or weak)
- Nausea.
- Diarrhea.
- Fever.
3
Adcetris 50 mg is a medicine derived for use
alone or with other medications to treat adult
patients with certain sorts of cutaneous or
systemic ALCL (anaplastic large cell lymphoma),
PTCL (peripheral T-cell lymphoma), Hodgkin's
disease, or mycosis fungoides. The adcetris 50 mg
is also being evaluated in the treatment of other
sorts of cancer. Adcetris mainly contains a
monoclonal antibody that helps bind to a protein
named CD30, which is found on certain lymphoma
cells. Adcetris 50 mg also contains an anticancer
drug, which destroys cancer cells. Adcetris is a
sort of ADC (antibody-drug conjugate). Also
addressed as brentuximab vedotin and SGN-35.
- ADCETRIS For HODGKINS LYMPHOMA TREATMENT
4
(No Transcript)
